**Question:** What is the dose adjustment required for insulin in a patient who is diagnosed as stage IV CKD

**Core Concept:** Dose adjustments of insulin are crucial in patients with Chronic Kidney Disease (CKD) due to the potential for reduced insulin clearance and increased risk of hypoglycaemia.

**Why the Correct Answer is Right:** In stage IV CKD, there is a significant decrease in the clearance of insulin, leading to increased risks of hypoglycaemia. As a result, a lower insulin dose is required to maintain euglycaemia.

**Why Each Wrong Option is Incorrect:**

A. This choice is incorrect as it does not address the specific need for reduced insulin clearance in patients with stage IV CKD.
B. While adjusting insulin dose based on CKD stage is important, this option does not account for the specific risk of hypoglycaemia due to reduced insulin clearance in stage IV CKD patients.
C. This answer does not address the need for reduced insulin clearance and increased risk of hypoglycaemia in stage IV CKD patients.
D. Choice D is the correct answer, as it acknowledges the need for reduced insulin clearance and increased risk of hypoglycaemia in stage IV CKD patients.

**Why Option D is Right:** In stage IV CKD, insulin clearance is decreased, leading to higher insulin levels and an increased risk of hypoglycaemia. Therefore, a lower insulin dose is necessary to maintain euglycaemia.

**Clinical Pearl:** In patients with stage IV CKD, an individualized approach to insulin dosing is crucial, considering the reduced insulin clearance and increased risk of hypoglycaemia. Close monitoring and adjustments to insulin doses are essential to ensure optimal glycaemic control without causing severe hypoglycaemia.